Tevogen (TVGN) Notes Payables (2023 - 2026)
Tevogen's (TVGN) quarterly Notes Payables came in at $1.7 million in Q1 2026, little changed on a YoY basis from $1.7 million in Q1 2025, and little changed quarter-over-quarter from $1.7 million in Q4 2025.
Analysis
Tevogen (TVGN) Notes Payables (2023 - 2026) Analysis & Trends
Tevogen (TVGN) has reported Notes Payables for 4 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Notes Payables changed 0.0% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (changed 0.0% YoY), and the FY2025 full-year result was $1.7 million, changed 0.0% from the prior year.
- Notes Payables held at $1.7 million in Q1 2026 per TVGN's latest filing, from $1.7 million in the prior quarter.
- Across five years, Notes Payables topped out at $80.7 million in Q4 2023 and bottomed at $625694.0 in Q2 2023.
- Historically, Notes Payables has averaged $8.1 million across 4 years, with a median of $1.7 million in 2024.
- The widest YoY moves for Notes Payables: up 163.87% in 2024, down 97.95% in 2024.
- Over 4 years, Notes Payables stood at $80.7 million in 2023, then sank by 97.95% to $1.7 million in 2024, then changed by 0.0% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
- According to Business Quant data, Notes Payables over the past three periods registered $1.7 million, $1.7 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Tevogen | 27.76 Mn | 27.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 80.71 Mn |
| Sep 30, 2023 | 625,694.00 |
| Jun 30, 2023 | 625,694.00 |